Leon Wang
Stock Analyst at Barclays
(2.83)
# 1,754
Out of 4,876 analysts
11
Total ratings
71.43%
Success rate
18.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Leon Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $40 → $63 | $99.49 | -36.68% | 5 | May 29, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Equal-Weight | $104 → $32 | $8.43 | +279.60% | 3 | May 10, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $47.52 | +24.16% | 3 | Sep 12, 2023 |
Insmed
May 29, 2024
Maintains: Overweight
Price Target: $40 → $63
Current: $99.49
Upside: -36.68%
RAPT Therapeutics
May 10, 2024
Downgrades: Equal-Weight
Price Target: $104 → $32
Current: $8.43
Upside: +279.60%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $47.52
Upside: +24.16%